{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:07:49Z","timestamp":1781878069842,"version":"3.54.5"},"reference-count":84,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1111\/ane.13039","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T06:33:55Z","timestamp":1539930835000},"page":"106-117","source":"Crossref","is-referenced-by-count":14,"title":["Movement disorders associated with neuronal antibodies"],"prefix":"10.1155","volume":"139","author":[{"given":"Deepa","family":"Dash","sequence":"first","affiliation":[{"name":"Department of Neurology; All India Institute of Medical Sciences; New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-9137","authenticated-orcid":false,"given":"Sanjay","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Neurology; Govind Ballabh Pant Postgraduate Institute of Medical Education and Research; New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"issue":"7","key":"10.1111\/ane.13039-BIB0001|ane13039-cit-0001","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens-pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1111\/ane.13039-BIB0002|ane13039-cit-0002","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1111\/ane.13039-BIB0003|ane13039-cit-0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1111\/ane.13039-BIB0004|ane13039-cit-0004","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1111\/ane.13039-BIB0005|ane13039-cit-0005","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain J Neurol"},{"issue":"16","key":"10.1111\/ane.13039-BIB0006|ane13039-cit-0006","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"issue":"7","key":"10.1111\/ane.13039-BIB0007|ane13039-cit-0007","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens-pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1111\/ane.13039-BIB0008|ane13039-cit-0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome","volume":"10","author":"Lim","year":"2014","journal-title":"J Clin Neurol Seoul Korea"},{"issue":"2","key":"10.1111\/ane.13039-BIB0009|ane13039-cit-0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1111\/ane.13039-BIB0010|ane13039-cit-0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"issue":"12-13","key":"10.1111\/ane.13039-BIB0011|ane13039-cit-0011","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s12098-016-2092-4","article-title":"Clinical characteristics and follow-up of South Indian children with autoimmune encephalopathy","volume":"83","author":"Sudan","year":"2016","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1111\/ane.13039-BIB0012|ane13039-cit-0012","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/mds.25354","article-title":"The spectrum of movement disorders in children with anti-NMDA receptor encephalitis","volume":"28","author":"Baizabal-Carvallo","year":"2013","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"12","key":"10.1111\/ane.13039-BIB0013|ane13039-cit-0013","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s00415-016-8282-1","article-title":"Clinical characteristics and outcomes between children and adults with anti-N-methyl-D-aspartate receptor encephalitis","volume":"263","author":"Huang","year":"2016","journal-title":"J Neurol"},{"issue":"2","key":"10.1111\/ane.13039-BIB0014|ane13039-cit-0014","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejpn.2018.01.012","article-title":"Pediatric NMDAR encephalitis: A single center observation study with a closer look at movement disorders","volume":"22","author":"Granata","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1111\/ane.13039-BIB0015|ane13039-cit-0015","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2018-318584","article-title":"The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study","author":"Varley","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"37","key":"10.1111\/ane.13039-BIB0016|ane13039-cit-0016","doi-asserted-by":"crossref","first-page":"e4365","DOI":"10.1097\/MD.0000000000004365","article-title":"Variations of movement disorders in anti-N-methyl-D-aspartate receptor encephalitis: a nationwide study in Taiwan","volume":"95","author":"Duan","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1111\/ane.13039-BIB0017|ane13039-cit-0017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0035-1569464","article-title":"Clinical features, therapeutic response, and follow-up in pediatric anti-N-methyl-D-aspartate receptor encephalitis: experience from a Tertiary Care University Hospital in India","volume":"47","author":"Nagappa","year":"2016","journal-title":"Neuropediatrics"},{"issue":"12","key":"10.1111\/ane.13039-BIB0018|ane13039-cit-0018","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/mds.25999","article-title":"Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies","volume":"29","author":"Mohammad","year":"2014","journal-title":"Mov Disord"},{"issue":"8","key":"10.1111\/ane.13039-BIB0019|ane13039-cit-0019","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/INF.0000000000001205","article-title":"Anti-N-methyl-D-aspartate receptor antibody mediated neurologic relapse post herpes simplex encephalitis: a case series","volume":"35","author":"Geoghegan","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1111\/ane.13039-BIB0020|ane13039-cit-0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1111\/ane.13039-BIB0021|ane13039-cit-0021","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.25626","article-title":"N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse","volume":"29","author":"Hacohen","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"10.1111\/ane.13039-BIB0022|ane13039-cit-0022","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1093\/jpids\/piu054","article-title":"Pediatric herpes simplex virus encephalitis complicated by N-methyl-D-aspartate receptor antibody encephalitis","volume":"4","author":"Bamford","year":"2015","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"9","key":"10.1111\/ane.13039-BIB0023|ane13039-cit-0023","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Spanish Herpes Simplex Encephalitis Study Group. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1111\/ane.13039-BIB0024|ane13039-cit-0024","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/dmcn.13448","article-title":"Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases","volume":"59","author":"Nosadini","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1111\/ane.13039-BIB0025|ane13039-cit-0025","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1111\/ane.13039-BIB0026|ane13039-cit-0026","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain J Neurol"},{"issue":"1","key":"10.1111\/ane.13039-BIB0027|ane13039-cit-0027","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ana.22470","article-title":"Faciobrachial dystonic attacks: seizures or movement disorder?","volume":"70","author":"Striano","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1111\/ane.13039-BIB0028|ane13039-cit-0028","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1111\/ane.13039-BIB0029|ane13039-cit-0029","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jnnp-2011-301506","article-title":"Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia","volume":"83","author":"Becker","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1111\/ane.13039-BIB0030|ane13039-cit-0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1111\/ane.13039-BIB0031|ane13039-cit-0031","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1111\/ane.13039-BIB0032|ane13039-cit-0032","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.0000000000001326","article-title":"Antibodies to GABAA receptor \u03b11 and \u03b32 subunits: clinical and serologic characterization","volume":"84","author":"Pettingill","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1111\/ane.13039-BIB0033|ane13039-cit-0033","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/00207454.2017.1408618","article-title":"The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy","volume":"128","author":"Cui","year":"2018","journal-title":"Int J Neurosci"},{"issue":"17","key":"10.1111\/ane.13039-BIB0034|ane13039-cit-0034","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"H\u00f6ftberger","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1111\/ane.13039-BIB0035|ane13039-cit-0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"issue":"20","key":"10.1111\/ane.13039-BIB0036|ane13039-cit-0036","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"},{"issue":"17","key":"10.1111\/ane.13039-BIB0037|ane13039-cit-0037","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies","volume":"82","author":"Balint","year":"2014","journal-title":"Neurology"},{"issue":"14","key":"10.1111\/ane.13039-BIB0038|ane13039-cit-0038","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1111\/ane.13039-BIB0039|ane13039-cit-0039","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1111\/ane.13039-BIB0040|ane13039-cit-0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"18","key":"10.1111\/ane.13039-BIB0041|ane13039-cit-0041","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"issue":"Pt 11","key":"10.1111\/ane.13039-BIB0042|ane13039-cit-0042","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain J Neurol"},{"issue":"1","key":"10.1111\/ane.13039-BIB0043|ane13039-cit-0043","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mds.25623","article-title":"Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-methyl-D-aspartate receptor or dopamine-2 receptor","volume":"29","author":"Mohammad","year":"2014","journal-title":"Mov Disord"},{"issue":"Pt 8","key":"10.1111\/ane.13039-BIB0044|ane13039-cit-0044","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain J Neurol"},{"issue":"22","key":"10.1111\/ane.13039-BIB0045|ane13039-cit-0045","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/01.wnl.0000436617.40779.65","article-title":"Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders","volume":"81","author":"Alexopoulos","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1111\/ane.13039-BIB0046|ane13039-cit-0046","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype","volume":"70","author":"McKeon","year":"2013","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1111\/ane.13039-BIB0047|ane13039-cit-0047","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1111\/ane.13039-BIB0048|ane13039-cit-0048","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol"},{"issue":"24","key":"10.1111\/ane.13039-BIB0049|ane13039-cit-0049","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"issue":"22","key":"10.1111\/ane.13039-BIB0050|ane13039-cit-0050","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis with mGluR5 antibodies: symptoms and antibody effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"key":"10.1111\/ane.13039-BIB0051|ane13039-cit-0051","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000212375","article-title":"Stiff person syndrome","volume":"26","author":"Duddy","year":"2009","journal-title":"Front Neurol Neurosci"},{"issue":"Pt 10","key":"10.1111\/ane.13039-BIB0052|ane13039-cit-0052","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"issue":"9","key":"10.1111\/ane.13039-BIB0053|ane13039-cit-0053","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S0004-282X2012000900002","article-title":"Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series","volume":"70","author":"Fernandes","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"issue":"8","key":"10.1111\/ane.13039-BIB0054|ane13039-cit-0054","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol"},{"issue":"15","key":"10.1111\/ane.13039-BIB0055|ane13039-cit-0055","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1212\/WNL.0b013e3182a8254f","article-title":"Orthostatic tremor heralding the onset of stiff-person syndrome","volume":"81","author":"Vetrugno","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"10.1111\/ane.13039-BIB0056|ane13039-cit-0056","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/brain\/awq253","article-title":"Stiff person syndrome associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition","volume":"133","author":"Geis","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1111\/ane.13039-BIB0057|ane13039-cit-0057","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0038-1660851","article-title":"Autoimmune movement disorders","volume":"38","author":"Fearon","year":"2018","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1111\/ane.13039-BIB0058|ane13039-cit-0058","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplastic accompaniments","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann Neurol"},{"issue":"24","key":"10.1111\/ane.13039-BIB0059|ane13039-cit-0059","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"issue":"1-2","key":"10.1111\/ane.13039-BIB0060|ane13039-cit-0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jneuroim.2014.07.011","article-title":"Non-stiff anti-amphiphysin syndrome: clinical manifestations and outcome after immunotherapy","volume":"274","author":"Moon","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.1111\/ane.13039-BIB0061|ane13039-cit-0061","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.0b013e3182886991","article-title":"Autoimmune chorea in adults","volume":"80","author":"O'Toole","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"10.1111\/ane.13039-BIB0062|ane13039-cit-0062","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.nrl.2013.10.007","article-title":"Chorea secondary to striatal encephalitis due to anti-CV2\/CRMP5 antibodies. Case description and review of the literature","volume":"30","author":"Crespo-Burillo","year":"2015","journal-title":"Neurologia"},{"issue":"11","key":"10.1111\/ane.13039-BIB0063|ane13039-cit-0063","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s00415-011-6074-1","article-title":"Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience","volume":"258","author":"Vigliani","year":"2011","journal-title":"J Neurol"},{"issue":"4","key":"10.1111\/ane.13039-BIB0064|ane13039-cit-0064","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies","volume":"80","author":"Honnorat","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.13039-BIB0065|ane13039-cit-0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jocn.2016.02.032","article-title":"Paraneoplastic syndrome mimicking progressive supranuclear palsy","volume":"32","author":"Dash","year":"2016","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1111\/ane.13039-BIB0066|ane13039-cit-0066","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.50.3.652","article-title":"Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies","volume":"50","author":"Lucchinetti","year":"1998","journal-title":"Neurology"},{"issue":"24","key":"10.1111\/ane.13039-BIB0067|ane13039-cit-0067","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1212\/WNL.0b013e318296e9c3","article-title":"Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer","volume":"80","author":"Honnorat","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1111\/ane.13039-BIB0068|ane13039-cit-0068","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/pbc.23131","article-title":"Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma","volume":"58","author":"Morales La Madrid","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1111\/ane.13039-BIB0069|ane13039-cit-0069","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archneurol.2010.209","article-title":"Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2(anti-Ri)","volume":"67","author":"Pittock","year":"2010","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1111\/ane.13039-BIB0070|ane13039-cit-0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.parkreldis.2012.05.013","article-title":"'Jaw clenching' in anti-Ri-antibody-associated paraneoplastic syndrome","volume":"19","author":"Bekircan-Kurt","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1111\/ane.13039-BIB0071|ane13039-cit-0071","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","article-title":"REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis","volume":"30","author":"Compta","year":"2007","journal-title":"Sleep"},{"issue":"1","key":"10.1111\/ane.13039-BIB0072|ane13039-cit-0072","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/practneurol-2013-000524","article-title":"Upbeat nystagmus in anti-Ma2 encephalitis","volume":"14","author":"Garcia-Reitboeck","year":"2014","journal-title":"Pract Neurol"},{"issue":"3","key":"10.1111\/ane.13039-BIB0073|ane13039-cit-0073","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-1331.2006.01152.x","article-title":"Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies","volume":"13","author":"Krolak-Salmon","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.13039-BIB0074|ane13039-cit-0074","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jocn.2017.03.045","article-title":"Anti-Yo, chorea and hemiballismus: a case report","volume":"42","author":"Goldstein","year":"2017","journal-title":"J Clin Neurosci"},{"issue":"4","key":"10.1111\/ane.13039-BIB0075|ane13039-cit-0075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1111\/ane.13039-BIB0076|ane13039-cit-0076","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13039-BIB0077|ane13039-cit-0077","doi-asserted-by":"crossref","first-page":"e0121364","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxyl- ase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1111\/ane.13039-BIB0078|ane13039-cit-0078","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13039-BIB0079|ane13039-cit-0079","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.13039-BIB0080|ane13039-cit-0080","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2011-301237","article-title":"Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition","volume":"83","author":"Zuliani","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1111\/ane.13039-BIB0081|ane13039-cit-0081","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune therapy in autoimmune encephalitis: a systematic review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1111\/ane.13039-BIB0082|ane13039-cit-0082","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.13039-BIB0083|ane13039-cit-0083","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.0b013e3182886991","article-title":"Autoimmune chorea in adults","volume":"80","author":"O\u2019Toole","year":"2013","journal-title":"Neurology"},{"key":"10.1111\/ane.13039-BIB0084|ane13039-cit-0084","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/dmcn.12882","article-title":"Symptomatic treatment of children with anti-NMDAR encephalitis","volume":"58","author":"Mohammad","year":"2016","journal-title":"Dev Med Child Neurol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.13039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.13039\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:46:56Z","timestamp":1671540416000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.13039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.13039","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,6]]}}}